Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "R03B" (45)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Beclometasone (R03BA01) 5 products
WHO-DDD
DrugBank.ca
IP
CI
Qvar Autohaler 100 µg
200 inhalation(s)
20.00
38.15
10 %
Metered dose aerosol: Beclometasoni Dipropionas 100 µg
Teva Pharma AG
B / SL
FB
G
IP
CI
Beclo Orion Easyhaler
200
28.79
47.75
10 %
Inhalation Powder: Beclometasoni Dipropionas 200 µg
Orion Pharma AG
B / SL
FB
G
IP
CI
Qvar Autohaler 50 µg
100 inhalation(s)
PR
PR
k.A.
Metered dose aerosol: Beclometasoni Dipropionas 50 µg
Teva Pharma AG
B
FB
G
IP
CI
Qvar Autohaler 50 µg
200 inhalation(s)
PR
PR
k.A.
Metered dose aerosol: Beclometasoni Dipropionas 50 µg
Teva Pharma AG
B
FB
G
IP
CI
Qvar Autohaler 100 µg
100 inhalation(s)
PR
PR
k.A.
Metered dose aerosol: Beclometasoni Dipropionas 100 µg
Teva Pharma AG
B
FB
G
Budesonide (R03BA02) 12 products
WHO-DDD
DrugBank.ca
IP
CI
Pulmicort Respules 0,25
mg/mL
20 1 ampoule(s) à 2 ml
21.29
39.20
10 %
Suspension: Budesonidum
AstraZeneca AG
B / SL / SO
FB
G
IP
CI
Pulmicort Respules 0,5
mg/mL
20 1 ampoule(s) à 2 ml
39.32
58.60
10 %
Suspension: Budesonidum
AstraZeneca AG
B / SL / SO
FB
G
IP
CI
Miflonide Breezhaler 200 mcg
60
9.12
26.35
10 %
Inhalation Powder: Budesonidum 200 µg
Novartis Pharma
Schweiz AG
B / SL / SG
FB
G
IP
CI
Miflonide Breezhaler 400 mcg
60
18.24
36.25
10 %
Inhalation Powder: Budesonidum 400 µg
Novartis Pharma
Schweiz AG
B / SL / SG
FB
G
IP
CI
Budenid Steri-Nebs
0.5mg/2ml
20 piece(s)
15.37
33.15
10 %
Gebrauchsfertige Suspension für Aerosolgeräte: Budesonidum
Teva Pharma AG
●
B / SL / SG
FB
G
IP
CI
Budenid Steri-Nebs
1mg/2ml
20 piece(s)
29.96
49.00
10 %
Gebrauchsfertige Suspension für Aerosolgeräte: Budesonidum
Teva Pharma AG
●
B / SL / SG
FB
G
IP
CI
Pulmicort Turbuhaler 100
200 unidose(s)
16.90
34.80
10 %
Inhalation Powder: Budesonidum 100 µg
AstraZeneca AG
B / SL
FB
G
IP
CI
Pulmicort Turbuhaler 200
200 unidose(s)
33.78
53.15
10 %
Inhalation Powder: Budesonidum 200 µg
AstraZeneca AG
B / SL
FB
G
IP
CI
Pulmicort Turbuhaler 400
50 unidose(s)
16.90
34.80
10 %
Inhalation Powder: Budesonidum 400 µg
AstraZeneca AG
B / SL
FB
G
IP
CI
Pulmicort Respules 0,125
mg/mL
20 1 ampoule(s) à 2 ml
16.82
34.70
10 %
Suspension: Budesonidum
AstraZeneca AG
B / SL
FB
G
IP
CI
Budenid Steri-Nebs
0.5mg/2ml
60 piece(s)
PR
PR
k.A.
Gebrauchsfertige Suspension für Aerosolgeräte: Budesonidum
Teva Pharma AG
B
FB
G
IP
CI
Budenid Steri-Nebs
1mg/2ml
60 piece(s)
PR
PR
k.A.
Gebrauchsfertige Suspension für Aerosolgeräte: Budesonidum
Teva Pharma AG
B
FB
G
Fluticasone (R03BA05) 8 products
WHO-DDD
DrugBank.ca
IP
CI
Axotide 50
inhalation(s) à 0.05 mg
7.73
17.65
10 %
Metered dose aerosol: Fluticasoni Propionas 50 µg
GlaxoSmithKline AG
●
B / SL
FB
G
IP
CI
Axotide 125
inhalation(s) à 0.125 mg
16.87
34.75
10 %
Metered dose aerosol: Fluticasoni Propionas 125 µg
GlaxoSmithKline AG
●
B / SL
FB
G
IP
CI
Axotide 250
inhalation(s) à 0.25 mg
26.84
45.60
10 %
Metered dose aerosol: Fluticasoni Propionas 250 µg
GlaxoSmithKline AG
●
B / SL
FB
G
IP
CI
Axotide Diskus 100
60 inhalation(s)
7.73
17.65
10 %
Mutlidosen-Pulverinhalator: Fluticasoni Propionas 100 µg
GlaxoSmithKline AG
B / SL
FB
G
IP
CI
Axotide Diskus 250
60 inhalation(s)
16.87
34.75
10 %
Mutlidosen-Pulverinhalator: Fluticasoni Propionas 250 µg
GlaxoSmithKline AG
B / SL
FB
G
IP
CI
Axotide Diskus 500
60 inhalation(s)
26.84
45.60
10 %
Mutlidosen-Pulverinhalator: Fluticasoni Propionas 500 µg
GlaxoSmithKline AG
B / SL
FB
G
IP
CI
Axotide Nebules 0,5 mg/2 mL
10 unidose(s)
9.06
18.60
k.A.
gebrauchsfertige Suspension zur Inhalation: Fluticasoni-17 Propionas
GlaxoSmithKline AG
B
FB
G
IP
CI
Axotide Nebules 2 mg/2 mL
10 unidose(s)
32.80
54.05
k.A.
gebrauchsfertige Suspension zur Inhalation: Fluticasoni-17 Propionas 2 mg
GlaxoSmithKline AG
B
FB
G
Ciclesonide (R03BA08) 2 products
WHO-DDD
DrugBank.ca
SIP
IP
CI
Alvesco 80 ug
120 inhalation(s)
20.33
38.55
10 %
Metered dose aerosol: Ciclesonidum 80 µg
Covis Pharma GmbH
B / SL
FB
G
SIP
IP
CI
Alvesco 160 ug
120 inhalation(s)
25.45
44.10
10 %
Metered dose aerosol: Ciclesonidum 160 µg
Covis Pharma GmbH
B / SL
FB
G
Fluticasone Furoate (R03BA09) 5 products
WHO-DDD
DrugBank.ca
IP
CI
Arnuity Ellipta 90 mcg
30 unidose(s)
15.60
33.40
10 %
Einzeldosiertes Pulver zur Inhalation: Fluticasoni Furoas 90 µg
GlaxoSmithKline AG
B / SL
FB
G
IP
CI
Arnuity Ellipta 90 mcg
3 x 30
46.80
67.30
10 %
Einzeldosiertes Pulver zur Inhalation: Fluticasoni Furoas 90 µg
GlaxoSmithKline AG
B / SL
FB
G
IP
CI
Arnuity Ellipta 182 mcg
30 unidose(s)
25.58
44.25
10 %
Einzeldosiertes Pulver zur Inhalation: Fluticasoni Furoas 182 µg
GlaxoSmithKline AG
B / SL
FB
G
IP
CI
Arnuity Ellipta 182 mcg
3 x 30
76.74
99.90
10 %
Einzeldosiertes Pulver zur Inhalation: Fluticasoni Furoas 182 µg
GlaxoSmithKline AG
B / SL
FB
G
IP
Arnuity Ellipta 46 mcg
30
PR
PR
k.A.
Einzeldosiertes Pulver zur Inhalation: Fluticasoni Furoas 46 µg
GlaxoSmithKline AG
B
FB
G
Ipratropium Bromide (R03BB01) 3 products
WHO-DDD
DrugBank.ca
IP
CI
Atrovent 250 mcg/2 ml
60 unidose(s)
17.33
34.85
10 %
Lösung für einen Vernebler (gebrauchsfertige Einzeldosen): Ipratropii Bromidum Anhydricum 250µg / 2ml
Boehringer Ingelheim
(Schweiz) GmbH
B / SL / SO
FB
G
IP
CI
Atrovent N
200 inhalation(s)
9.52
26.75
10 %
Metered dose aerosol: Ipratropii Bromidum 21 µg
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
CI
Atrovent
15 ml
13.12
29.80
k.A.
Metered dose aerosol: Ipratropii Bromidum 20 µg
Boehringer Ingelheim
(Schweiz) GmbH
B
FB
G
Tiotropium Bromide (R03BB04) 4 products
WHO-DDD
SIP
IP
CI
Spiriva 18 mcg
30 Capsule(s)
29.98
49.00
10 %
Inhalation Powder: Tiotropium 18 µg
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
SIP
IP
CI
Spiriva 18 mcg
90 Capsule(s)
88.66
112.85
10 %
Inhalation Powder: Tiotropium 18 µg
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
IP
CI
Spiriva Respimat 2.5 mcg
29.98
49.00
10 %
Lösung zur Inhalation (wiederverwendbar): Tiotropium 2.5 µg
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
IP
CI
Spiriva Respimat 2.5 mcg
3
88.66
112.85
10 %
Lösung zur Inhalation (wiederverwendbar): Tiotropium 2.5 µg
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
Aclidinium Bromide (R03BB05) 2 products
WHO-DDD
DrugBank.ca
IP
CI
PP
Eklira Genuair
piece(s)
37.46
57.15
10 %
Inhalation Powder: Aclidinii Bromidum 375 µg
Covis Pharma GmbH
B / SL
FB
G
IP
CI
PP
Eklira Genuair
3 piece(s)
103.54
129.00
10 %
Inhalation Powder: Aclidinii Bromidum 375 µg
Covis Pharma GmbH
B / SL
FB
G
Glycopyrronium Bromide (R03BB06) 2 products
WHO-DDD
DrugBank.ca
IP
CI
PP
Seebri Breezhaler
30 Capsule(s)
35.38
54.90
10 %
Mikrogramm: Glycopyrronium 50 µg
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
CI
PP
Seebri Breezhaler
90 Capsule(s)
106.13
131.85
10 %
Mikrogramm: Glycopyrronium 50 µg
Novartis Pharma
Schweiz AG
B / SL
FB
G
Umeclidinium Bromide (R03BB07) 2 products
WHO-DDD
DrugBank.ca
IP
CI
Incruse Ellipta
30 unidose(s)
34.64
54.10
10 %
Inhalation Powder: Umeclidinium 62.5 µg
GlaxoSmithKline AG
B / SL
FB
G
IP
CI
Incruse Ellipta
3 x 30 unidose(s)
103.00
128.45
10 %
Inhalation Powder: Umeclidinium 62.5 µg
GlaxoSmithKline AG
B / SL
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
